Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 225 of 500 entries
View as:

A Study of MK0476 in the Treatment of Asthma Patients Aged 2-5 Years (0476-907)

Phase: N/A Priority: Normal
NCT ID: NCT00700661 Org: User:
Start: 01/31/01 End: 12/31/02 Due: 12/31/03

Nasonex (Mometasone Furoate Nasal Spray) in Adenoids Hypertrophy in Children (P04367)

Phase: N/A Priority: Normal
NCT ID: NCT01098071 Org: User:
Start: 08/01/08 End: 09/01/09 Due: 09/01/10

Study to Test Rizatriptan in the Early Treatment of Acute Migraine (0462-081)

Phase: N/A Priority: Normal
NCT ID: NCT00516737 Org: User:
Start: 10/03/07 End: 04/08/08 Due: 04/08/09

Effects on Hemostasis, Lipids, Carbohydrate Metabolism, Adrenal & Thyroid Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG-EE (292004)(COMPLETED)(P05764)

Phase: N/A Priority: Normal
NCT ID: NCT00511355 Org: User:
Start: 10/31/06 End: 01/31/08 Due: 01/31/09

Montelukast in Seasonal Allergic Rhinitis: Fall 2001 Study (0476-240)

Phase: N/A Priority: Normal
NCT ID: NCT00963469 Org: User:
Start: 08/31/01 End: 11/30/01 Due: 11/30/02

Ezetimibe Plus (+) Simvastatin Versus Atorvastatin Comparative Study (0653A-092)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00166504 Org: User:
Start: 10/31/05 End: 10/31/07 Due: 10/31/08

Study of Mometasone Furoate Nasal Spray and Oxymetazoline Nasal Spray Given Together Once A Day To Treat Seasonal Allergic Rhinitis (P04500)

Phase: N/A Priority: Normal
NCT ID: NCT00552110 Org: User:
Start: 07/31/07 End: 02/29/08 Due: 02/28/09

Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With Primary Hypercholesterolemia and Coronary Heart Disease (P03396)

Phase: N/A Priority: Normal
NCT ID: NCT00650689 Org: User:
Start: 05/31/03 End: 12/31/04 Due: 12/31/05

A Study of Ezetimibe Added On to Rosuvastatin Versus Up Titration of Rosuvastatin in Patients With Hypercholesterolemia (MK0653-139)

Phase: N/A Priority: Normal
NCT ID: NCT00783263 Org: User:
Start: 11/30/08 End: 05/31/10 Due: 05/31/11

Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in COPD (Study P04229AM4)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00383435 Org: User:
Start: 10/31/06 End: 07/31/10 Due: 07/31/11

Safety and Efficacy of Mometasone Furoate (SCH 032088) vs Beclomethasone Dipropionate or Placebo in Seasonal Allergic Rhinitis (C93-013)

Phase: N/A Priority: Normal
NCT ID: NCT03855189 Org: User:
Start: 08/23/93 End: 10/22/93 Due: 10/22/94

A Study of Safety and Efficacy in MK-0954A Combination in Participants With Hypertension (MK-0954A-373 AM3)

Phase: N/A Priority: Normal
NCT ID: NCT01431508 Org: User:
Start: 08/01/07 End: 06/01/09 Due: 06/01/10

Multi-center, Pediatric, Open-label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec 5.0 mg Chewable Tablet Medications (Study P04574)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00779116 Org: User:
Start: 09/30/05 End: 10/31/05 Due: 10/31/06

Rizatriptan 5 mg and 10 mg, Sumatriptan 100 mg, and Placebo Comparison Study (0462-030)

Phase: N/A Priority: Normal
NCT ID: NCT00898677 Org: User:
Start: 09/30/95 End: 09/30/96 Due: 09/30/97

Study of Investigational Drug in Osteoporosis (MK-0217-908)

Phase: N/A Priority: Normal
NCT ID: NCT00092053 Org: User:
Start: 12/31/04 End: 07/31/05 Due: 07/31/06

Multi-Center, Pediatric, Open-Label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec ® 5.0 mg Chewable Tablet Medications (Study P04573) (Completed)

Phase: N/A Priority: Normal
NCT ID: NCT00780403 Org: User:
Start: 08/31/05 End: 10/31/05 Due: 10/31/06

Post-Authorization Safety Surveillance Study of Asenapine in Participants With Bipolar Disorder (P08307)

Phase: N/A Priority: Normal
NCT ID: NCT01495741 Org: User:
Start: 07/01/13 End: 12/18/17 Due: 12/18/18

A Phase 2 Trial to Evaluate if Corifollitropin Alfa (Org 36286), Followed by a Low Daily Dose of hCG or Recombinant FSH Can Induce Monofollicular Growth in Women With WHO Group II Anovulatory Infertility (P05693)

Phase: N/A Priority: Normal
NCT ID: NCT00697255 Org: User:
Start: 05/15/07 End: 05/15/08 Due: 05/15/09

Monitor the Incidence of Congenital Malformations in Infants of Women Who Have Been Treated With Ganirelix (Orgalutran®)(Study 38644)(P05966)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00724789 Org: User:
Start: 11/30/00 End: 11/30/05 Due: 11/30/06

Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05690 (Care Program) (P05710)

Phase: N/A Priority: Normal
NCT ID: NCT00702624 Org: User:
Start: 04/30/07 End: 06/30/08 Due: 06/30/09

Predictive Factors for Ovarian Stimulation Using a Fixed Daily Dose of 200 IU Recombinant FSH (Study 142003)(P05696)

Phase: N/A Priority: Normal
NCT ID: NCT00778999 Org: User:
Start: 10/01/06 End: 07/24/08 Due: 07/24/09

Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05583)

Phase: N/A Priority: Normal
NCT ID: NCT00728416 Org: User:
Start: 08/31/08 End: 10/31/08 Due: 10/31/09

A Study of the Bronchodilator Effect of Formoterol Fumarate Used in Combination With Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P06476 AM2)

Phase: N/A Priority: Normal
NCT ID: NCT01258803 Org: User:
Start: 12/31/10 End: 10/31/11 Due: 10/31/12

Study of Asenapine in Elderly Subjects With Psychosis (A7501021)(P05717)

Phase: N/A Priority: Normal
NCT ID: NCT00281320 Org: User:
Start: 02/28/06 End: 12/31/08 Due: 12/31/09

A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)

Phase: N/A Priority: Normal
NCT ID: NCT01208181 Org: User:
Start: 09/27/10 End: 07/29/14 Due: 07/29/15